Epidemiological characteristics of overseas imported COVID-19 cases into China: A scoping literature review.

Zitong Zhang, Yifeng Chen, Qingyu Li, Yan Yang, Jiake Chen, Yan Lin, Zhihong Xiao, Marie Ma, Chuancheng Wu, Baoying Liu, Rongxian Xu, Jianjun Xiang
Author Information
  1. Zitong Zhang: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  2. Yifeng Chen: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  3. Qingyu Li: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  4. Yan Yang: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  5. Jiake Chen: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  6. Yan Lin: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  7. Zhihong Xiao: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  8. Marie Ma: Magill Medical Center, Adelaide, SA, Australia.
  9. Chuancheng Wu: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  10. Baoying Liu: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  11. Rongxian Xu: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.
  12. Jianjun Xiang: School of Public Health, Fujian Medical University, Fuzhou, Fujian Province, China.

Abstract

Previous studies investigating the characteristics of imported cases were mostly limited to a certain province/city or a specific sub-group during a certain period with a small sample size, which may not provide an overall picture of the characteristics of imported cases. In this scoping literature review, we comprehensively synthesized the epidemiological characteristics of overseas imported COVID-19 cases into China by retrieving six literature databases, with aims to provide implications for more targeted control, prevention, and medical treatment of this disease. After dropping duplicates and reviewing titles, abstracts, and full-texts, 50 articles were included in the review finally, including 26 (52%) articles in English and 24 (48%) articles in Chinese. According to the type of data sources, the 50 studies were divided into three categories: 13 (26%) articles using data sourced from the Chinese Infectious Diseases Online Reporting System, 15 (30%) articles using data from the websites of national/local health departments, and 22 (44%) articles using hospital admission data. Most of the overseas imported COVID-19 cases were young and middle-aged Chinese students and businessmen returning from the United States, Europe, and some neighboring countries. Airport routine health screening measures could not identify COVID-cases effectively, although scheduled multiple nucleic acid tests were required before boarding. Almost all imported cases were identified during the hotel quarantine period. Although a large proportion of imported cases were asymptomatic or with mild symptoms in the published literature, they may be due to participant selection bias. The exact proportion of asymptomatic cases may need to be further investigated especially through population-based large-scale studies.

Keywords

References

  1. Sci Rep. 2021 Mar 22;11(1):6483 [PMID: 33753799]
  2. BMJ Support Palliat Care. 2021 Jul 30;: [PMID: 34330791]
  3. Risk Manag Healthc Policy. 2021 Sep 21;14:3955-3963 [PMID: 34584473]
  4. Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Apr 10;43(4):478-482 [PMID: 35443300]
  5. PLoS Negl Trop Dis. 2020 Dec 7;14(12):e0008908 [PMID: 33284804]
  6. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Mar 28;47(3):344-351 [PMID: 35545327]
  7. Aust N Z J Public Health. 2020 Aug;44(4):257-259 [PMID: 32697418]
  8. Int J Environ Res Public Health. 2019 Nov 21;16(23): [PMID: 31766548]
  9. N Engl J Med. 2020 Mar 19;382(12):1177-1179 [PMID: 32074444]
  10. Glob Health Action. 2022 Dec 31;15(1):2124645 [PMID: 36285582]
  11. Medicine (Baltimore). 2021 Aug 27;100(34):e26933 [PMID: 34449458]
  12. Jpn J Infect Dis. 2022 Jul 22;75(4):361-367 [PMID: 34980704]
  13. J Formos Med Assoc. 2020 Jul;119(7):1180-1184 [PMID: 32386675]
  14. PLoS One. 2021 Apr 14;16(4):e0248818 [PMID: 33852593]
  15. PLoS One. 2021 Dec 23;16(12):e0261840 [PMID: 34941947]
  16. Int J Gen Med. 2021 May 25;14:2069-2078 [PMID: 34079347]
  17. J Infect. 2020 Jun;80(6):e43-e44 [PMID: 32283157]
  18. JAMA Netw Open. 2022 Aug 1;5(8):e2228008 [PMID: 35994285]
  19. Lancet Reg Health West Pac. 2023 Jan 7;:100678 [PMID: 36643735]
  20. BMC Infect Dis. 2022 Jan 17;22(1):59 [PMID: 35039000]
  21. Travel Med Infect Dis. 2020 May - Jun;35:101653 [PMID: 32247926]
  22. Infect Drug Resist. 2022 Apr 22;15:2115-2125 [PMID: 35498630]
  23. Biomed Environ Sci. 2022 May 20;35(5):393-401 [PMID: 35676810]
  24. High Educ Policy. 2022;35(3):651-672 [PMID: 35465059]
  25. Lancet Reg Health West Pac. 2021 Aug;13:100184 [PMID: 34179860]
  26. Trop Med Health. 2020 Mar 9;48:14 [PMID: 32165854]
  27. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Dec 10;42(12):2088-2095 [PMID: 34954969]
  28. Am J Transl Res. 2021 Oct 15;13(10):11999-12005 [PMID: 34786134]
  29. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1786-1790 [PMID: 33297639]
  30. J Complex Netw. 2021 Mar 07;8(6):cnaa041 [PMID: 34191993]
  31. BMC Infect Dis. 2021 Mar 6;21(1):245 [PMID: 33676420]
  32. Front Public Health. 2021 May 03;9:604455 [PMID: 34012950]
  33. Infect Drug Resist. 2022 Jun 24;15:3295-3307 [PMID: 35774303]
  34. Int J Environ Res Public Health. 2020 May 09;17(9): [PMID: 32397515]
  35. BMJ Open. 2020 Sep 16;10(9):e041079 [PMID: 32938604]
  36. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Dec 10;42(12):2082-2087 [PMID: 34954968]
  37. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Dec 10;41(12):2034-2039 [PMID: 33378813]
  38. J Microbiol Immunol Infect. 2021 Feb;54(1):12-16 [PMID: 32425996]
  39. PLoS One. 2022 Apr 14;17(4):e0267081 [PMID: 35421199]
  40. Emerg Microbes Infect. 2020 Dec;9(1):1230-1232 [PMID: 32515651]
  41. Int J Infect Dis. 2020 Sep;98:51-58 [PMID: 32579906]
  42. Nan Fang Yi Ke Da Xue Xue Bao. 2020 May 30;40(5):741-745 [PMID: 32897209]
  43. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Aug 10;42(8):1365-1370 [PMID: 34814555]
  44. J Travel Med. 2020 Dec 23;27(8): [PMID: 32841347]

MeSH Term

Humans
China
Cities
COVID-19
Time Factors
Travel

Word Cloud

Created with Highcharts 10.0.0importedcasesarticlescharacteristicsliteraturereviewCOVID-19datastudiesmayoverseasChineseusingcertainperiodprovidescopingepidemiologicalChina50healthproportionasymptomaticPreviousinvestigatingmostlylimitedprovince/cityspecificsub-groupsmallsamplesizeoverallpicturecomprehensivelysynthesizedretrievingsixdatabasesaimsimplicationstargetedcontrolpreventionmedicaltreatmentdiseasedroppingduplicatesreviewingtitlesabstractsfull-textsincludedfinallyincluding2652%English2448%Accordingtypesourcesdividedthreecategories:1326%sourcedInfectiousDiseasesOnlineReportingSystem1530%websitesnational/localdepartments2244%hospitaladmissionyoungmiddle-agedstudentsbusinessmenreturningUnitedStatesEuropeneighboringcountriesAirportroutinescreeningmeasuresidentifyCOVID-caseseffectivelyalthoughscheduledmultiplenucleicacidtestsrequiredboardingAlmostidentifiedhotelquarantineAlthoughlargemildsymptomspublisheddueparticipantselectionbiasexactneedinvestigatedespeciallypopulation-basedlarge-scaleEpidemiologicalChina:

Similar Articles

Cited By